- “Chemotherapy Drug May Reverse Signs of Aging” (FoxNews)
- “US Biotech Isolagen files for bankruptcy protection” (Reuters)
- “MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE, a Global Phase 2/3 Clinical Trial of Teplizumab in Type 1 Diabetes” (Press release issued by MacroGenics and Eli Lilly and Co. (PRNewsWire)
Read the rest of this entry »
THE LATEST WORD
Top Industry Stories – June 16, 2009
Posted on June 16th, 2009 | by Rxmedyn | No Comments »Posted in Industry Stories
Top Industry Stories – June 15, 2009
Posted on June 15th, 2009 | by Rxmedyn | No Comments »- “Asthma drugs to display more prominent psychiatric warning” (Pharma Times)
- “China’s Sinovac enters race for flu vaccine” (Reuters)
- “Eli Lilly and Company Announces New Drug Discovery Initiative” (Press release issued by Eli Lilly and Company, PRNewswire)
Read the rest of this entry »
Posted in Industry Stories
Top Industry Stories – June 12, 2009
Posted on June 12th, 2009 | by Rxmedyn | No Comments »- “Inspire Announces Presentations at European Cystic Fibrosis Society Annual Meeting” (Press release issued by Inspire Pharmaceuticals, Inc., Trading Markets)
- “Vertex CEO touts billion-dollar potential of telaprevir” (Smart Brief)
- “Recession favors minimally invasive procedures” (Grinza)
- “Novartis boosted by swine flu worries” (Financial Times)
- “Abraxis Bioscience Launches ABRAXANE® in China for Women with Metastatic Breast Cancer” (EarthTimes)
- “UPDATE 1-US FDA cites safety issues with Savient gout drug” (Reuters)
- “Bristol-Myers Says Anti-rheumatic Drug Orencia Shows Consistent Safety and Effectiveness Over Long Term” (RTT News)
- “Medicis to Present At Jefferies Healthcare Conference” (Press release issued by Medicis, Trading Markets)
- “Via Pharmaceuticals Meets FDA On Cardiovascular Drug” (Pharmaceutical Business Review)
Posted in Industry Stories
Top Industry Stories – June 11, 2009
Posted on June 11th, 2009 | by Rxmedyn | No Comments »- “AEterna Zentaris Initiates Extended Study For Benign Prostatic Hyperplasia” (Pharmaceutical Business Review)
- “FDA Is Urged to Approve Drugs for Adolescent Use” (Washington Post)
- “Staar Surgical gets FDA nod for lens insertion device” (Reuters)
- “Sleep drug co Neurim reports positive Phase III results” (Globes)
- “US FDA: data suggests risk with Wyeth’s Rapamune” (Reuters)
Posted in Industry Stories
Top Industry Stories – June 10, 2009
Posted on June 10th, 2009 | by Rxmedyn | No Comments »- “Talecris Biotherapeutics Receives Orphan Drug Designation for Plasmin (Human) to Treat Acute Peripheral Arterial Occlusion” (Press release issued by Talecris Biotherapeutics, Business Wire)
- “Gilead Sciences (GILD) PriceWatch Alert Shows Bearish Technicals” (Market Intelligence Center)
- “New Products: Rx, OTC, generics (June 2009)” (Modern Medicine)
Read the rest of this entry »
Posted in Industry Stories
Top Industry Stories – June 9, 2009
Posted on June 9th, 2009 | by Rxmedyn | No Comments »- “Luminex launches cystic fibrosis tests in Europe” (The Associated Press, CNBC)
- “Vertex swaps $103.3 million in notes for stock” (The Associated Press, Forbes)
- “Concern About Antioxidants and Breast Cancer” (The New York Times)
Read the rest of this entry »
Posted in Industry Stories
Top Industry Stories – June 8, 2009
Posted on June 8th, 2009 | by Rxmedyn | No Comments »Posted in Industry Stories
Top Industry Stories – June 5, 2009
Posted on June 5th, 2009 | by Rxmedyn | No Comments »- “Depression diagnoses decline after FDA warning” (Atlanta Journal Constitution)
- “Bart Peterson to Join Lilly Leadership Team” (Press release issued by Lilly, PR Newswire)
- “Merck, Glaxo Diarrhea Vaccine Endorsed for Global Use (Update1)” (Bloomberg)
Read the rest of this entry »
Posted in Industry Stories
TOP INDUSTRY STORIES – June 4, 2009
Posted on June 4th, 2009 | by Rxmedyn | No Comments »- “Eli Lilly resubmits Cymbalta as chronic pain drug” (BusinessWeek)
- “J&J lays out plans for 11 new drug approvals” (FierceBiotech)
- “J&J upbeat on drugs business, cites new medicines” (Reuters)
- “Merck and AstraZeneca: rivals join forces in oncology” (Press release issued by Merck & Co, TradingMarkets.com)
- “Novartis, Wellcome Trust To Develop Vaccine For Typhoid Fever” (Pharmaceutical Business Review)
- “Pfizer tries new uses for failed drugs” (St. Louis Post-Dispatch)
- “FDA urged to halt review on prasugrel over safety issues” (PharmaTimes)
Posted in Industry Stories
SUBSCRIBE-
Recent Posts
Archives
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
Careers | © 2009 Medical Dynamics